Refine by
Cannabidiol Equipment Supplied In Europe
10 equipment items found
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
GW is committed to developing new medicines to treat rare, treatment-resistant epilepsy conditions where there are limited or in some cases, no approved treatment ...
Manufactured by:Futura Medical based inGuildford, UNITED KINGDOM
Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
Sativex® (delta-9-tetrahydrocannibinol and cannabidiol in the EU; nabiximols in the US) is an oromucosal spray of a formulated cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD), as well as specific minor cannabinoids and other non-cannabinoid components. ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
Our proprietary complex botanical mixture, called nabiximols (Sativex® outside of the U.S.) is an oromucosal spray of a formulated cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) as well as specific minor cannabinoids and other non-cannabinoid components. GW developed nabiximols to be administered as an ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
Schizophrenia is a chronic disease that manifests through disturbances of perception, thought, cognition, emotion, motivation and motor activity. Over a lifetime, about 1% of the population will develop ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
Many of the childhood-onset intractable epilepsy conditions within the expanded access program share considerable overlap with ASD and these conditions often fall within the orphan disease space. Initial clinical observations from treating physicians suggest a potential role for cannabinoids in addressing problems associated with ASD such as deficits in cognition, behavior, and ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
Naturally occurring cannabis contains a group of chemical compounds not found in other plants known as cannabinoids. Over 80 different cannabinoids have so far been identified but the role and importance of many of these has yet to be fully understood. GW is researching a large number of cannabinoids, each of which has different effects and ...
Manufactured by:FeyeCon based inWeesp, NETHERLANDS
FeyeCon processes active ingredients using methods ranging from extraction to formulation. We obtain ingredients from a wide variety of natural sources with CO₂ extraction. A unique characteristic of this technology is its versatility – it is possible to perform selective extraction and obtain different actives from one source. After extraction the valuable components are encapsulated ...
Manufactured by:InStar Technologies a.s. based inLiberec, CZECH REPUBLIC
Cebedix & Cebidix-h are an Oral Thin Films using our InStripTM technology with CBD (Canabidiol). InStrip technology allows you to use the full potential of the substances contained in Cebedix, in this case CBD. You will achieve the desired effect from a much smaller dose. And a smaller dose means a smaller toll on the organism. The first effects of Cebedix in the form of a thin, ...
by:GW Pharmaceuticals plc based inCambridge, UNITED KINGDOM
NHIE is acute or sub-acute brain injury due to asphyxia caused during birth resulting from deprivation of oxygen during birth (hypoxia) as a result of a sentinel event such as ruptured placenta, parental shock and even increased heart rate. Hypoxic damage can occur to most of the infant’s organs, but brain damage is the most serious and least likely to heal, resulting in encephalopathy. ...